Chromosomal imbalances in pleomorphic rhabdomyosarcomas and identification of the alveolar rhabdomyosarcoma-associated PAX3-FOXO1A fusion gene in one case

Cancer Genetics and Cytogenetics

Volumn 140, Issue 1, 2003, Pages 73-77

  Gordon, Anthony ^a   McManus, Aidan ^a   Anderson, John ^b   Fisher, Cyril ^c   Abe, Syuiti ^d   Nojima, Takayuki ^e   Pritchard Jones, Kathy ^a   Shipley, Janet ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

^d HOKKAIDO UNIVERSITY   (Japan)

^e KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMPLICON; ANAPLASTIC CARCINOMA; ARTICLE; CANCER CLASSIFICATION; CELL TYPE; CHROMOSOME ABERRATION; CHROMOSOME GAIN; CHROMOSOME LOSS; CHROMOSOME STRUCTURE; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FUSION GENE; GENE AMPLIFICATION; GENE IDENTIFICATION; HUMAN; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; OSTEOSARCOMA; PRIORITY JOURNAL; RHABDOMYOSARCOMA;

AGED; AGED, 80 AND OVER; ANEUPLOIDY; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; DNA-BINDING PROTEINS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; ONCOGENE PROTEINS, FUSION; OSTEOSARCOMA; PAIRED BOX TRANSCRIPTION FACTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; RHABDOMYOSARCOMA, ALVEOLAR; SOFT TISSUE NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0037241962     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00631-3     Document Type: Article

References (25)

1. Hawkins W.G., Hoos A., Antonescu C.R., Urist M.J., Leung D.H., Gold J.S., Woodruff J.M., Lewis J.J., Brennan M.F. Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer. 91:2001;794-803.
2. Enzinger F., Weiss S. Soft tissue tumours. 1994;Mosby, St. Louis.
3. Douglass E.C., Valentine M., Etcubanas E., Parham D., Webber B.L., Houghton P.J., Houghton J.A., Green A.A. A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet. 45:1987;148-155.
4. Kullendorff C.M., Donner M., Mertens F., Mandahl N. Chromosomal aberrations in a consecutive series of childhood rhabdomyosarcoma. Med Pediatr Oncol. 30:1998;156-159.
5. Mertens F., Fletcher C.D., Dal Cin P., De Wever I., Mandahl N., Mitelman F., Rosai J., Rydholm A., Sciot R., Tallini G., Van den Berghe H., Vanni R., Willen H. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features. a report of the CHAMP Study Group. Chromosomes and morphology Genes Chromosomes Cancer. 22:1998;16-25.
6. Sonobe H., Takeuchi T., Taguchi T., Shimizu K., Furihata M., Ohtsuki Y. A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1, exhibiting MyoD1 and myogenin. Int J Oncol. 17:2000;119-125.
7. Hollowood K., Fletcher C.D. Rhabdomyosarcoma in adults. Semin Diagn Pathol. 11:1994;47-57.
8. Parham D. Pathological classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol. 14:2001;506-514.
9. Gaffney E.F., Dervan P.A., Fletcher C.D. Pleomorphic rhabdomyosarcoma in adulthood. Analysis of 11 cases with definition of diagnostic criteria. Am J Surg Pathol. 17:1993;601-609.
10. Anderson J., Gordon A., Pritchard-Jones K., Shipley J. Genes, chromosomes, and rhabdomyosarcoma. Genes Chromosomes Cancer. 26:1999;275-285.
11. Downing J.R., Khandekar A., Shurtleff S.A., Head D.R., Parham D.M., Webber B.L., Pappo A.S., Hulshof M.G., Conn W.P., Shapiro D.N. Multiplex RT-PCR assay for the differential diagnosis of alveolar rhabdomyosarcoma and Ewing's sarcoma. Am J Pathol. 146:1995;626-634.
12. Chen B.F., Chen M.L., Liang D.C., Huang Y.W., Liu H.C., Chen S.H. Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue. Zhonghua Yi Xue Za Zhi (Taipei). 62:1999;86-91.
13. Kilpatrick S.E., Teot L.A., Geisinger K.R., Martin P.L., Shumate D.K., Zbieranski N., Russell G.B., Fletcher C.D. Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Comparison of flow cytometry and image analysis. Cancer. 74:1994;3227-3233.
14. Kallioniemi O.P., Kallioniemi A., Piper J., Isola J., Waldman F.M., Gray J.W., Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer. 10:1994;231-243.
15. Weber-Hall S., Anderson J., McManus A., Abe S., Nojima T., Pinkerton R., Pritchard-Jones K., Shipley J. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res. 56:1996;3220-3224.
16. Anderson J., Renshaw J., McManus A., Carter R., Mitchell C., Adams S., Pritchard-Jones K. Amplification of the t(2;13) and t(1;13) translocations of alveolar rhabdomyosarcoma in small formalin-fixed biopsies using a modified reverse transcriptase polymerase chain reaction. Am J Pathol. 150:1997;477-482.
17. McManus A.P., O'Reilly M.A., Jones K.P., Gusterson B.A., Mitchell C.D., Pinkerton C.R., Shipley J.M. Interphase fluorescence in situ hybridization detection of t(2;13)(q35;q14) in alveolar rhabdomyosarcoma - a diagnostic tool in minimally invasive biopsies. J Pathol. 178:1996;410-414.
18. Pandita A., Zielenska M., Thorner P., Bayani J., Godbout R., Greenberg M., Squire J.A. Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma. Neoplasia. 1:1999;262-275.
19. Bridge J.A., Liu J., Weibolt V., Baker K.S., Perry D., Kruger R., Qualman S., Barr F., Sorensen P., Triche T., Suijkerbuijk R. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization. an intergroup rhabdomyosarcoma study Genes Chromosomes Cancer. 27:2000;337-344.
20. Bridge J.A., Liu J., Qualman S., Suijkerbuijk R., Wenger G., Zhang J., Wan X., Baker K., Sorenson P., Barr F. Genomic gains and losses are similar in genetic histologic subsets of rhabdomyosarcomas and amplification predominates in embryonal with anaplasia and alveolar subtypes. Genes Chromosomes Cancer. 33:2002;310-321.
21. Gordon A.T., Brinkschmidt C., Anderson J., Coleman N., Dockhorn-Dworniczak B., Pritchard-Jones K., Shipley J. A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma. Genes Chromosomes Cancer. 28:2000;220-226.
22. Knuutila S., Bjorkqvist A.M., Autio K., Tarkkanen M., Wolf M., Monni O., Szymanska J., Larramendy M.L., Tapper J., Pere H., El-Rifai W., Hemmer S., Wasenius V.M., Vidgren V., Zhu Y. DNA copy number amplifications in human neoplasms. review of comparative genomic hybridization studies Am J Pathol. 152:1998;1107-1123.
23. Larramendy M.L., Tarkkanen M., Blomqvist C., Virolainen M., Wiklund T., Asko-Seljavaara S., Elomaa I., Knuutila S. Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol. 151:1997;1153-1161.
24. El-Rifai W., Sarlomo-Rikala M., Knuutila S., Miettinen M. DNA copy number changes in development and progression in leiomyosarcomas of soft tissues. Am J Pathol. 153:1998;985-990.
25. Stindl R., Fiegl M., Regele H., Gisslinger H., Breitenseher M.J., Fonatsch C. Alveolar rhabdomyosarcoma in a 68-year-old patient identified by cytogenetic analysis of bone marrow. Cancer Genet Cytogenet. 107:1998;43-47.